Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings.
Adolescent
Adult
Aged
Aged, 80 and over
Child
Disease Progression
Eye Proteins
/ genetics
Female
Fluorescein Angiography
Humans
Macular Degeneration
/ diagnosis
Male
Middle Aged
Photoreceptor Cells, Vertebrate
/ physiology
Retina
/ diagnostic imaging
Retinal Pigment Epithelium
/ physiology
Tomography, Optical Coherence
Visual Acuity
/ physiology
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 11 2019
01 11 2019
Historique:
entrez:
15
11
2019
pubmed:
15
11
2019
medline:
1
2
2020
Statut:
ppublish
Résumé
To determine the course of occult macular dystrophy (OMD, Miyake's disease) and to propose stages of OMD based on the optical coherence tomographic (OCT) findings. Sixty-one patients from 33 families with OMD who carried one of the proven variants of the RP1L1 gene were studied at seven centers in Japan. Ophthalmological examinations including the best-corrected visual acuity (BVCA) and OCT were performed. The median age at the last visit was 50 years with a range of 10 to 88 years, and the median age at the symptom onset was 30 years with a range of 3 to 60 years. There were significant negative correlations between the duration of OMD and BCVA, the central retinal thickness (CRT) and the thickness between external limiting membrane and retinal pigment epithelium (ERT). The BCVA gradually decreased for 10 years after symptom onset and was stable thereafter. Kaplan-Meier survival curves of the BCVA and retinal thickness showed that all of the patients had retained a vision of 1.0 logMAR, and over 80% of the patients had retained 50% thickness of the normal CRT and ERT for at least 60 years after symptom onset. The stages of OMD based on the visual symptoms and OCT findings are proposed. The photoreceptors do not become completely atrophic even at the late stage, which may account for the good retinal pigment epithelium (RPE) structure and normal-appearing fundus. The proposed stages facilitate the investigation of the pathogenicity of OMD and provide information to determine the effectiveness of therapeutic procedures.
Identifiants
pubmed: 31725168
pii: 2755677
doi: 10.1167/iovs.19-27486
doi:
Substances chimiques
Eye Proteins
0
RP1L1 protein, human
0
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM